What is Global Viscosupplementation Injection Market?
The Global Viscosupplementation Injection Market is a rapidly growing sector in the healthcare industry. Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. This procedure is most commonly used to treat symptoms of knee osteoarthritis. The global market for these injections was valued at a substantial US$ 1140.2 million in 2022. This value is expected to increase significantly, reaching an estimated US$ 1688.5 million by 2029. This growth represents a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period of 2023-2029.
Single Injection, Three Injection, Five Injection in the Global Viscosupplementation Injection Market:
The Viscosupplementation Injection Market is segmented based on the number of injections required for the treatment. These segments include Single Injection, Three Injection, and Five Injection. The Single Injection treatment involves a one-time injection into the affected joint. The Three Injection treatment involves three separate injections, usually administered one week apart. The Five Injection treatment involves five separate injections, typically administered one week apart. Each of these treatments has its own advantages and disadvantages, and the choice of treatment often depends on the patient's specific condition and needs.
Hospitals, Clinics, Others in the Global Viscosupplementation Injection Market:
The majority of Viscosupplementation Injections are used in hospitals, accounting for 55% of the total usage. However, these injections are also used in clinics and other healthcare facilities. The use of these injections in hospitals is likely due to the fact that the procedure requires a healthcare professional and is often performed in conjunction with other treatments. In clinics, these injections are often used as a standalone treatment for patients with knee osteoarthritis.
Global Viscosupplementation Injection Market Outlook:
North America is the largest consumer of Viscosupplementation Injections, accounting for nearly 52% of the global consumption. This high consumption rate is likely due to the high prevalence of knee osteoarthritis in this region, as well as the availability of advanced healthcare facilities and trained healthcare professionals. However, the market for these injections is also growing in other regions, as awareness of this treatment option increases and more healthcare facilities begin to offer it.
| Report Metric | Details |
| Report Name | Viscosupplementation Injection Market |
| Accounted market size in 2022 | US$ 1140.2 million |
| Forecasted market size in 2029 | US$ 1688.5 million |
| CAGR | 5.7% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
